Brief: Oramed And Lifeward Announce Strategic Transaction
13/01/2026 12:59
Jan 13 (Reuters) - Lifeward Ltd 2RW.MU: ORAMED AND LIFEWARD ANNOUNCE STRATEGIC TRANSACTION ORAMED PHARMACEUTICALS INC - TO RECEIVE 49.9% OWNERSHIP IN LIFEWARD ORAMED PHARMACEUTICALS INC - MARK GRANT TO LEAD COMBINED PLATFORMS ORAMED PHARMACEUTICALS INC - LIFEWARD TO ISSUE $10 MILLION CONVERTIBLE NOTES ORAMED PHARMACEUTICALS INC - WILL RECEIVE 4% ON NET SALES OF REWALK FRANCHISE FOR UP TO 10 YEARS Source text: ID:nPnwV5H2a Further company coverage: 2RW.MU ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lifeward
See all newsBrief: Lifeward Announces Collaboration With Shirley Ryan Abilitylab To Expand Access For The Rewalk Personal Exoskeleton
Brief: Lifeward To Acquire Powered Upper Body Exoskeleton With Ai Capabilities
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM